Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Genetic Technologies Sponsored ADR Representing 30 Ord Shs GENE

Technology Scientific & Technical Instruments
Genetic Technologies Limited is an Australia-based diversified molecular diagnostics company. The Company is engaged in providing genomics-based tests on health, wellness and serious disease through its geneType and EasyDNA brands. The Company offers cancer predictive testing and assessment tools to help physicians to improve health outcomes for people around the world. The Company has a... see more

Recent & Breaking News (NDAQ:GENE)

Genetic Technologies, Groundbreaking Predictive Testing and Assessment Tools

Press Releases May 14, 2019

Genetic Technologies Limited (ASX Code: GTG; NASDAQ Ticker: GENE) announces successful completion of two new ground-breaking Genetic Risk Tests - for Colorectal Cancer and for Breast Cancer

GlobeNewswire May 10, 2019

Genetic Technologies Receives Nasdaq Notification Letter

GlobeNewswire May 3, 2019

Genetic Technologies and The Translational Genomics Research Institute of Phoenix, Arizona Sign Memorandum of Understanding

GlobeNewswire April 15, 2019

Genetic Technologies Asian Operations Established in Hainan, China

GlobeNewswire April 11, 2019

Genetic Technologies Limited Announces Research Collaboration with Two World-Renowned Medical Centres

GlobeNewswire February 1, 2019

Genetic Technologies Limited Provides End of Year Update on the Test Development Program

GlobeNewswire December 21, 2018

Genetic Technologies Limited Announces New Biomedical Blockchain Joint Venture

GlobeNewswire December 20, 2018

The Daily Biotech Pulse: Axovant In-Licenses 2 Gene Therapies, Agile To Undertake Additional Study Of Contraceptive Patch

Benzinga.com  December 14, 2018

Genetic Technologies Invited to Establish a Market Presence in Hainan, China

GlobeNewswire September 17, 2018

Genetic Technologies Limited Invited by Representatives of the Hainan Government to Discuss Market Entry into China

GlobeNewswire August 21, 2018

Genetic Technologies Announces Proposed Joint Venture with Beijing Zishan Health Consultancy Limited

GlobeNewswire August 16, 2018

Genetic Technologies Secures A$20 Million Equity Placement Facility

GlobeNewswire August 8, 2018

Genetic Technologies Formalises Strategic Alliance with Blockchain Global

GlobeNewswire August 2, 2018

Genetic Technologies Announces Appointment of Swisstec as Non-Exclusive Asian Distributor

GlobeNewswire July 30, 2018

Genetic Technologies Limited Announces Expansion of Genetic Risk Assessment Tests and October Launch of New Breast Cancer and Colorectal Cancer Tests

GlobeNewswire July 16, 2018

Genetic Technologies Announces Heads of Agreement with Swisstec

GlobeNewswire June 19, 2018

Genetic Technologies Announces Binding Project Shivom Agreement

GlobeNewswire June 7, 2018

Genetic Technologies Announces Grant from NHMRC Awarded to University of Melbourne to Substantially Improve Breast Cancer Risk Prediction and Increase Accessibility 

GlobeNewswire May 1, 2018

Genetic Technologies Limited Announces Further Collaborative Research with The University of Melbourne to Broaden the Applicability of the BREVAGenplus® Breast Cancer Risk Assessment Test

GlobeNewswire March 16, 2018